Some Tums tablets recalled due to fibreglass, paper, foil fragments

OTTAWA – Health Canada has announced a recall of certain Tums antacid tablets due to possible contamination with fragments of fibreglass, paper, aluminum foil and other materials.

The federal agency says on its website that manufacturer GlaxoSmithKline (GSK) Consumer Healthcare initiated the recall.

The affected products are peppermint regular strength tablets that are sold in a package of three rolls containing 12 tablets each.

They were distributed across Canada starting on Oct. 25. They have an expiry date of August 2027.

Health Canada says the fragments would pass through most people's digestive system with no concern, but elderly people and people who have narrow areas in their intestines due to disease or surgery could be at risk of injury.

It says anyone who has the affected tablets should stop consuming them.

Any questions about the recall should be directed to GSK Consumer Healthcare at 1-905-507-7000 or ca.chquality@haleon.com.

Tums antacids are used for relief of heartburn and indigestion.

For more information on the product being recalled visit Health Canada's web page here.

This report by The Canadian Press was first published Dec. 1, 2022.

This report has been produced with the financial assistance of the Canadian Medical Association. It has no say in editorial choices.